Dosing, side effects, plateaus: all easier to navigate with a care team who's done this before, not a form and a shipment.
In short: if other approaches haven't been enough, Zepbound (tirzepatide) is the medication with the most weight loss on average in head-to-head research. It's a once-weekly injection approved for chronic weight management and for obstructive sleep apnea in adults with obesity, and it works on two hormone pathways instead of one. The right dose, and the right pace, are different for everyone, which is what your physician manages.
Bryan went from a playing weight in football to putting on weight. Working with Dr. Billing, he lost almost 200 pounds and regained his life.
Skye spent a lifetime struggling with her weight. After learning about her options and talking with Dr. Billing, she found a solution that was right for her.
Sean reached a point where he wanted a serious effort and a long-term solution for himself and his family. He lost weight and found a sustainable path forward.
Explore flexible payment options with Cherry.
What makes Zepbound different is that it works on two hormone pathways instead of one, GLP-1 and GIP. Together they reduce appetite, help you feel full, and change how your body handles food. In head-to-head research, that second pathway translated into more weight loss on average.
Zepbound is also approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
Zepbound may be a fit if you:
It may not be right if you have a personal or family history of certain thyroid cancers, a history of pancreatitis, or are pregnant or planning to be. Zepbound can also make some birth control pills less effective for a period after starting and after each dose increase, so your physician will talk through backup options.
Zepbound can have gastrointestinal side effects. Managing those side effects is part of the care.
The most common are nausea, diarrhea, vomiting, constipation, and stomach discomfort. They tend to show up as the dose goes up and often ease with time. Going at the right pace is a big part of what your physician manages, and the goal is always the same: find the right dose for you.
Zepbound carries a boxed warning about thyroid C-cell tumors seen in animal studies, and it should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Other serious risks include pancreatitis, gallbladder problems, kidney problems, and low blood sugar when combined with certain diabetes medicines. It is not for use during pregnancy. Your physician reviews the full prescribing information and your health history before anything is prescribed.
Without insurance, the list price for Zepbound is roughly $1,000 a month or more. Lilly’s self-pay program currently offers Zepbound vials for about $299 to $449 a month depending on dose. Coverage depends on your plan and usually follows the FDA-approved use, so plans that cover weight management or sleep apnea treatment may cover Zepbound.
Our team verifies your benefits before you start and walks you through cash-pay and financing options. Prices change often; our cost and insurance guide has current numbers.
Stronger medicine asks more of the plan around it. Your physician decides when to step your dose up and when to hold, based on how you’re feeling rather than a fixed calendar. With less appetite, protein gets hard to hit, and losing muscle along with fat is the mistake we most want to prevent, so coaching and body composition scans keep you on track. And when a plateau comes, and one usually does, we adjust the plan instead of leaving you to wonder whether it stopped working.
If you eventually need more than medication, surgical options are here, with the same team.
Bottom line: Zepbound produced the most weight loss on average in head-to-head research, and strong medicine works best with careful pacing and a plan for protein, plateaus, and what comes after. Everybody’s different, and your plan should be too.
In a head-to-head trial, people taking tirzepatide (Zepbound) lost more weight on average than those taking semaglutide (Wegovy). The best choice still depends on your health history, coverage, and how you respond.
Both contain tirzepatide. Zepbound is approved for chronic weight management and obstructive sleep apnea in adults with obesity. Mounjaro is approved for type 2 diabetes.
It can make birth control pills less effective for a period after you start and after each dose increase. Your physician will recommend a backup method during those times.
Yes. Zepbound is FDA-approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
In the clinical trial behind its approval, adults on the highest dose lost about 21% of their body weight on average over 72 weeks. Results vary with dose, tolerance, and the plan around the medication.
List price is roughly $1,000 a month or more without insurance. Lilly’s self-pay program currently offers vials for about $299 to $449 a month depending on dose, and some plans cover Zepbound for weight management or sleep apnea.
